Michaels et al v. Genetic Design, Inc. et al
| Carrie Michaels, Michael Ashley and Marada Zumbahlen |
| Genetic Design, Inc., Genzyme Corporation, Laboratory Corporation of America d/b/a LabCorp, HSHS St. Anthony's Memorial Hospital, sanofi-aventis, LLC and Quest Diagnostics Clinical Laboratories, Inc. |
| 3:2023cv02021 |
| June 13, 2023 |
| US District Court for the Southern District of Illinois |
| Stephen P McGlynn |
| P.I.: Other |
| 28 U.S.C. § 1332 Diversity-Personal Injury |
| Defendant |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 21, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 34
ORDER Granting #33 MOTION to Appear Pro Hac Vice by Attorney Matthew Edward DePaz on behalf of Genzyme Corporation.(adh)THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED.
|
| Filing 33 MOTION to Appear Pro Hac Vice by Attorney Matthew Edward DePaz $200 fee paid,receipt number AILSDC-5153024 by on behalf of Genzyme Corporation. (DePaz, Matthew) |
| Filing 32 Summons Issued as to Quest Diagnostics Clinical Laboratories, Inc. as successor in interest to Physicians Clinical Laboratories, Inc. Original sent to counsel for service. (clw) |
| Filing 31 Summons Requested. (Gianaris, Ted) |
| Filing 30 NOTICE: On July 26, 2023, plaintiffs filed #25 Amended Complaint against Genzyme Corporation, as successor in interest to Genetic Design, Inc., and Quest Diagnostics Clinical Laboratories, Inc., as successor in interest to Physicians Clinical Laboratories, Inc. As such, HSHS St. Anthony's Memorial Hospital f/k/a Effingham Medical Center, Genetic Design, Inc., Laboratory Corporation of America d/b/a LabCorp, and Sanofi-Aventis have been terminated as defendants. Genzyme Corporation, as successor in interest to Genetic Design, Inc., shall file its answer or other responsive pleading on or before August 18, 2023. Quest Diagnostics Clinical Laboratories, Inc., as successor in interest to Physicians Clinical Laboratories, Inc., has not yet been served; therefore, there should not be an answer date. Signed by Judge Stephen P. McGlynn on 7/28/2023. (jce) THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED. |
| Filing 29 NOTICE of Appearance by Joshua A Edelson on behalf of All Plaintiffs (Edelson, Joshua) |
| Filing 28 NOTICE OF ACTION re #25 Amended Complaint, filed by Carrie Michaels, Marada Zumbahlen, Michael Ashley. See Local Rule 83.1(f). In all cases filed in, removed to, or transferred to this court, all attorneys, including government attorneys, shall file a written entry of appearance before addressing the court. Attorney Edelson does not have a Notice of Appearance on file in this case. (csb)THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED. |
| Filing 27 NOTICE REGARDING FILING re #25 Amended Complaint, filed by Carrie Michaels, Marada Zumbahlen, Michael Ashley. Login used and signature do not match. All pleadings are to be filed with the login for the attorney signing the document. This Notice is sent for informational purposes only. (csb)THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED. |
|
Filing 26
NOTICE AND ORDER: The Court is in receipt of #25 Amended Complaint. Accordingly, the pending Motions to Dismiss (Docs. #7 , #12 , and #23 ) are terminated as moot. Defendants shall file answer or other responsive pleading to Amended Complaint within 21 days, or by August 18, 2023. Signed by Judge Stephen P. McGlynn on 7/27/2023. (jce) THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED.
|
| Genzyme Corporation answer due 8/18/2023; Quest Diagnostics Clinical Laboratories, Inc. as successor in interest to Physicians Clinical Laboratories, Inc. answer due 8/18/2023. (aza) |
| Filing 25 AMENDED COMPLAINT against All Defendants, filed by All Plaintiffs. (Attachments: #1 Exhibit Exhibit A, #2 Exhibit Exhibit B, #3 Exhibit Exhibit C, #4 Exhibit Exhibit D, #5 Exhibit Exhibit E, #6 Exhibit Exhibit F, #7 Summons Summons of Service)(Gianaris, Ted) |
|
Filing 24
NOTICE AND ORDER: Plaintiffs are granted leave to file amended complaint within 21 days, or by August 8, 2023. If plaintiffs timely file an amended complaint, the pending motions to dismiss will be terminated and defendants shall then have 30 days within which to file responsive pleading. If plaintiffs do not file an amended complaint, plaintiffs shall file responses to the pending Motions to Dismiss within 30 days, or by August 18, 2023. Prior deadline of July 21, 2023 is hereby vacated and cancelled. (Amended Pleading due by 8/8/2023 or Responses due by 8/18/2023.). Signed by Judge Stephen P. McGlynn on 7/18/2023. (jce)
|
| Filing 23 MOTION to Dismiss Plaintiffs' Complaint and Incorporated Memorandum in Support by HSHS St. Anthony's Memorial Hospital. (Attachments: #1 Exhibit A - Plaintiff's Complaint)(Farley, Kelsey) |
| Filing 22 SUPPLEMENT to Notice of Removal re #1 Notice of Removal, by Genzyme Corporation, Sanofi-Aventis, LLC. (Second Supplement to Exhibit 5). (Attachments: #1 Supplement Michaels, C HSHS's Motion to Dismiss, #2 Supplement Michaels, C HSHS's Motion to Transfer FNC)(Schwettman, Tyler) |
|
Filing 21
NOTICE AND ORDER: The Court notes that this case was recently reassigned. Currently pending are two motions: #7 MOTION to Dismiss filed by Genzyme Corporation and sanofi-aventis US LLC; and, #12 MOTION to Dismiss filed by Laboratory Corporation of America. Plaintiff shall file any response to the aforementioned motions on or before July 21, 2021. (Responses due by 7/21/2023). Signed by Judge Stephen P. McGlynn on 6/28/2023. (jce)THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED.
|
| Filing 20 NOTICE OF MODIFICATION re #17 Sealed Document filed by Sanofi-Aventis, LLC, Genzyme Corporation. Incorrect event selected. Select the event that most closely matches the document being filed. For this document, the correct event is "CONSENT/NON CONSENT TO U.S. MAGISTRATE JUDGE" under the heading "Other Filings/ Other Documents". Docket text modified to reflect the correct document. No further action required by the filer. (jlh)THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED. |
| Filing 19 NOTICE TERMINATING JUDGE ASSIGNMENT: Pursuant to Administrative Order No. 347, and a request for reassignment having been received, this case, in its entirety, is hereby reassigned to Judge Stephen P. McGlynn for further proceedings. Magistrate Judge Gilbert C. Sison no longer assigned to the case. All future documents must bear case number 23-cv-2021-SPM. (jlh)THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED. |
| Filing 18 NOTICE of Appearance by Ted N. Gianaris on behalf of All Plaintiffs (Gianaris, Ted) |
| Filing 17 CONSENT/NON-CONSENT TO U.S. MAGISTRATE JUDGE - sealed pending receipt from all parties. (Schwettman, Tyler) Modified on 6/23/2023 (jlh). |
| Filing 16 CONSENT/NON-CONSENT TO U.S. MAGISTRATE JUDGE - sealed pending receipt from all parties. (Gianaris, Ted) |
| Filing 15 NOTICE FROM CLERK Instructing HSHS St. Anthony's Memorial Hospital to file Notice and Consent to Proceed Before A Magistrate Judge Jurisdiction Form: Pursuant to Administrative Order No. 347, within 21 days of this Notice, you must file the attached form indicating your consent to proceed before a Magistrate Judge or an affirmative declination to consent. A link regarding the magistrate judges in this district is attached for your convenience: #https://www.ilsd.uscourts.gov/documents/BenefitsofConsent.pdf. Consent/Non-Consent to U.S. Magistrate Judge Jurisdiction form sent to HSHS St. Anthony's Memorial Hospital on 6/22/2023. Consent due by 7/13/2023 (kek) |
| Filing 14 NOTICE of Appearance by Kelsey Alyse Johnson Farley on behalf of HSHS St. Anthony's Memorial Hospital (Farley, Kelsey) |
| Filing 13 NOTICE FROM CLERK Instructing Laboratory Corporation of America to file Notice and Consent to Proceed Before A Magistrate Judge Jurisdiction Form: Pursuant to Administrative Order No. 347, within 21 days of this Notice, you must file the attached form indicating your consent to proceed before a Magistrate Judge or an affirmative declination to consent. A link regarding the magistrate judges in this district is attached for your convenience: #https://www.ilsd.uscourts.gov/documents/BenefitsofConsent.pdf. Consent/Non-Consent to U.S. Magistrate Judge Jurisdiction form sent to Laboratory Corporation of America on 6/21/23. Consent due by 7/12/2023 (lmb) |
| Filing 12 MOTION to Dismiss for Lack of Jurisdiction , MOTION to Dismiss for Failure to State a Claim and Incorporated Memorandum in Support Thereof by Laboratory Corporation of America. (Attachments: #1 Exhibit A, Declaration of Dr. George C. Maha)(Caradonna, Thomas) |
| Filing 11 Federal Rule of Civil Procedure 7.1 Disclosure Statement by Laboratory Corporation of America identifying Corporate Parent Laboratory Corporation Of America Holdings for Laboratory Corporation of America. (Caradonna, Thomas) |
| Filing 10 NOTICE of Appearance by Sarah A. Milunski on behalf of Laboratory Corporation of America (Milunski, Sarah) |
| Filing 9 NOTICE of Appearance by Oliver Hensleigh Thomas on behalf of Laboratory Corporation of America (Thomas, Oliver) |
| Filing 8 NOTICE of Appearance by Thomas L. Caradonna on behalf of Laboratory Corporation of America (Caradonna, Thomas) |
| Filing 7 MOTION to Dismiss PLAINTIFFS COMPLAINT AND SUGGESTIONS IN SUPPORT by Genzyme Corporation, Sanofi-Aventis, LLC. (Schwettman, Tyler) |
| Filing 6 SUPPLEMENT to Notice of Removal re #1 Notice of Removal, by Genzyme Corporation, Sanofi-Aventis, LLC. Supplement to Exhibit 5. (Attachments: #1 Supplement MICHAELS,C HSHS'S MOTION TO DISMISS, #2 Supplement MICHAELS,C HSHS'S MOTION TO TRANSFER FNC)(Schwettman, Tyler) |
| Filing 5 NOTICE OF INITIAL ASSIGNMENT TO A U.S. MAGISTRATE JUDGE: This case has been randomly assigned to United States Magistrate Judge Gilbert C. Sison pursuant to Administrative Order 347. The parties are advised that their consent is required if the assigned Magistrate Judge is to conduct all further proceedings in this case, including trial and final entry of judgment pursuant to 28 U.S.C. 636(c) and Federal Rule of Civil Procedure 73. As set forth in Administrative Order No. 347, each party will be required to file a Notice and Consent to Proceed Before a Magistrate Judge Jurisdiction form indicating consent or non-consent to the jurisdiction of the assigned Magistrate Judge. If all parties do not consent to the Magistrate Judge's jurisdiction, the case will be randomly assigned to a district judge for all further proceedings and the parties cannot later consent to reassignment of the case to a magistrate judge. The parties are further advised that they are free to withhold consent without adverse substantive consequences. Within 21 days of this Notice, the following party or parties must file the attached form indicating consent to proceed before the assigned Magistrate Judge or an affirmative declination to consent: Genzyme Corporation, Sanofi-Aventis U.S. LLC. A link regarding the magistrate judges in this district is attached for your convenience: #https://www.ilsd.uscourts.gov/documents/BenefitsofConsent.pdf. All future documents must bear case number 3:23-cv-02021-GCS. Refer to Civil/Removal Case Processing Requirements, found on the ILSD website, for further service information. Consent due by 7/5/2023 (aza) |
| Filing 4 NOTICE of Appearance by Tyler W. Schwettman on behalf of Genzyme Corporation, sanofi-aventis, LLC (Schwettman, Tyler) |
| Filing 3 NOTICE by Genzyme Corporation, sanofi-aventis, LLC re #1 Notice of Removal, to Plaintiffs of Filing Notice of Removal (Attachments: #1 Exhibit Filed Notice of Removal)(Schwettman, Tyler) |
| Filing 2 Federal Rule of Civil Procedure 7.1 Disclosure Statement by Genzyme Corporation, sanofi-aventis, LLC identifying Corporate Parent Sanofi for Genzyme Corporation, sanofi-aventis, LLC. (Schwettman, Tyler) |
| Filing 1 NOTICE OF REMOVAL from 20th Judicial Circuit St. Clair County, Illinois, case number 2023-LA-0540 ( Filing fee $ 402 receipt number AILSDC-5105622), filed by sanofi-aventis, LLC, Genzyme Corporation. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Civil Cover Sheet)(Schwettman, Tyler) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
